Structural defects in amyloid-β fibrils drive secondary nucleation
Jing Hu, Tom Scheidt, Dev Thacker…·Alexander J. Dear
This study shows that structural defects in amyloid-β fibrils are key sites for secondary nucleation, suggesting new strategies for drug design to inhibit amyloid disorders.